HeartWare HVAD Exchange to HeartMate3: Principles, Techniques, and Pitfalls

      Since the recall of the HeartWare HVAD device in 2021, the management of the remaining implants range from medical management, transplant, to exchange. This article describes 2 feasible approaches to exchange the HVAD to the HeartMate3 device through a combination of a left lateral thoracotomy with a superior hemi-sternotomy. These approaches minimize dissection and complications of a redo-sternotomy and minimizes bypass time. Pitfalls and solutions are also herein described.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Operative Techniques in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Potapov EV
        • Nersesian G
        • Lewin D
        • et al.
        Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices: The EUROMACS analysis.
        Eur J Cardiothorac Surg. 2021; 60: 579-587
        • Cho SM
        • Mehaffey JH
        • Meyers SL
        • et al.
        Cerebrovascular events in patients with centrifugal-flow left ventricular assist devices: Propensity score-matched analysis from the intermacs registry.
        Circulation. 2021; 144: 763-772
        • Pagani FD
        • Cantor R
        • Cowger J
        • et al.
        Concordance of treatment effect: An analysis of the society of thoracic surgeons intermacs database.
        Ann Thorac Surg. 2022; 113: 1172-1182
      1. Administration, US Food and Drug. Medtronic Recalls HVAD Pump Implant Kits Due to Delayed or Failed Restart After the Pump is Stopped. [Online] March 01, 2021. Available at: Accessed April 2022

        • Cogswell R
        • Cantor RS
        • Vorovich E
        • et al.
        HVAD to Heartmate 3 device exchange: A society of thoracic surgeons intermacs analysis.
        Ann Thorac Surg. 2021; S0003-4975: 01744-01746
        • Salerno CT
        • Hayward C
        • Hall S
        • et al.
        HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
        J Thorac Cardiovasc Surg. 2022; 163: 2120-2127
        • Hayward C
        • Adachi I
        • Baudart S
        • et al.
        Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support.
        J Thorac Cardiovasc Surg. 2022; 164(4): 1120-1137
      2. OPTN. Modify Heart Policy to Address Patient . s.l.: OPTN, 2022.

        • Thoratec Corporation
        HeartMate 3 Left Ventricular Assist System Instruction for Use.
        United States and Canada Thoratec Corporation, Pleasanton2017
        • Hanke JS
        • Dogan G
        • Haverich A
        • et al.
        Exchange of a HeartMate 3 left ventricular assist device through thoracotomy.
        Oper Tech Thorac Cardiovasc Surg. 2018; 23: 62-75
        • Hanke JS
        • Mariani S
        • Merzah AS
        • et al.
        Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate.
        J Cardiovas Surg. 2021; 62: 646-651
        • Hanke JS
        • Rojas SV
        • Dogan G
        • et al.
        First series of left ventricular assist device exchanges to HeartMate 3.
        Eur J Cardiothorac Surg. 2017; 51: 887-892
        • Bourque K
        • Martin MJ
        • Harjes DI
        • et al.
        Graft resistance difference after HVAD to HeartMate 3 left ventricular assist device exchange.
        Ann Thorac Surg. 2022; 21: 02170-02176

      Linked Article